Skip to content
WeighLab
Menu
Ranked #315 · Grade C

Tablet Health review

Tablet Health is a LegitScript-certified DTC telehealth platform selling compounded semaglutide and tirzepatide in both oral-tablet and injectable form, priced from $179/mo (oral semaglutide) to $299/mo (injectable tirzepatide).

Visit Tablet Health Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$199/mo (compounded)
Tirzepatide
$299/mo (compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Semaglutide · modeled / year

$2,388

Tirzepatide · modeled / year

$3,588

Pricing verified August 2026

The Index scorecard

Tablet Health scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month59/100
Price Transparency78/100
Nationwide Access24/100
Formulation Options77/100
Clinical Oversight50/100
Contract Flexibility55/100

Where the value is

  • LegitScript Certified — seal displayed on the site
  • Offers both oral-tablet and injectable forms of semaglutide AND tirzepatide, four distinct SKUs
  • Published per-product pricing rather than a single vague 'starting at' figure: $179-$299/mo across the four variants
  • 'No surprises, upfront pricing' messaging with fast, discreet shipping stated as included on all plans

The tradeoffs

  • States served are not published anywhere on the accessible site — eligibility is only revealed by completing the intake quiz
  • The homepage's 'Flat monthly pricing starting at $149' banner cannot be tied to any of the four listed $179-$299 tiers
  • No founder, CEO, medical director, or individual prescriber is named anywhere — only 'U.S.-licensed healthcare providers' as a category
  • The company's own NYC pharmacy is 'opening soon,' so all current dispensing runs through unnamed external partners

The bottom line

Best for: Cost-first shoppers who want an oral-tablet GLP-1 option at the lowest published tier ($179/mo), if you can tolerate no state-coverage list. Tablet Health is a LegitScript-certified DTC telehealth platform selling compounded semaglutide and tirzepatide in both oral-tablet and injectable form, priced from $179/mo (oral semaglutide) to $299/mo (injectable tirzepatide).

Ranked #315 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Tablet Health.

The 24 programs nearest this one

Pricing, states and verification reflect Tablet Health's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Tablet Health's site. Not medical advice; see our disclosure.

← Back to the value leaderboard